Cyclin E expression, a potential prognostic marker for non-small cell lung cancers

Clinical Cancer Research

Volumn 6, Issue 1, 2000, Pages 11-16

  Mishina, Takayuki ^a   Dosaka Akita, Hirotoshi ^a,b   Hommura, Fumihiro ^a   Nishi, Motoi ^a   Kojima, Tetsuya ^a   Ogura, Shigeaki ^a   Shimizu, Michio ^b   Katoh, Hiroyuki ^a   Kawakami, Yoshikazu ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CYCLIN E;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; DISEASE ACTIVITY; DISEASE MARKER; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

AGED; ANALYSIS OF VARIANCE; CARCINOMA, NON-SMALL-CELL LUNG; CYCLIN E; FEMALE; G1 PHASE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; S PHASE; SMOKING; SURVIVAL ANALYSIS;

EID: 0033968335     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Ginsberg, R. J., Vokes, E. E., and Raben, A. Non-small cell lung cancer. In: V. T. DeVita, S. Hellman, and S. A. Rosenberg (eds.), Cancer: Principles and Practice of Oncology, Ed. 5, pp. 858-910, Philadelphia: Lippincott-Raven Publishers, 1997.
2. Strauss, G. M., Kwiatkowski, D. J., Harpole, D. H., Lynch, T. J., Skarin, A. T., and Sugarbaker, D. J. Molecular and pathologic markers in stage I non-small cell carcinoma of the lung. J. Clin. Oncol., 13: 1265-1279, 1995.
3. Pastorino, U., Andreola, S., Tagliabue, E., Pezzella, F., Incarbone, M., Sozzi, G., Buyse, M., Menard, S., Pierotti, M., and Rilke, F. Immunocytochemical markers in stage I lung cancer: relevance to prognosis. J. Clin. Oncol., 15: 2858-2865, 1997.
4. Kwiatkowski, D. J., Harpole, D. H., Jr., Goleski, J., Herndon, J. E., II, Dar-Bin, S., Richards, W., Blanco, R., Xu, H., Strauss, G. M., and Sugarbaker, D. J. Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications. J. Clin. Oncol., 16: 2468-2477, 1998.
5. Minna, J. D., Sekido, Y., Fong, K. M., and Gazdar, A. F. Molecular biology of lung cancer. In: V. T. De Vita, S. Hellman, and S. A. Rosenberg (eds.), Cancer: Principles and Practice of Oncology, Ed. 5, pp. 849-857. Philadelphia: Lippincott-Raven Publishers, 1997.
6. Hunter, T., and Pines, J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell, 79: 573-582, 1994.
7. Sherr, C. J. Cancer cell cycle. Science (Washington DC), 274: 1672-1677, 1996.
8. Morgan, D. O. Principles of CDK regulation. Nature (Lond.), 374: 131-134, 1995.
9. Sherr, C. J. G1 phase progression: cycling on cue. Cell, 79: 551-555, 1994.
10. Sherr, C. J., and Roberts, J. M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev., 9: 1149-1163, 1995.
11. Reed, S. I., Bailley E., Dulic, V., Hengst, L., Resnitzky, D., and Slingerland, J. G1 control in mammalian cells. J. Cell Sci., 18: 69-73, 1994.
12. Bates, S., Bonetta L., MacAllan, D., Parry D., Holder, A., Dickson, C., and Peters, G. CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1. Oncogene, 9: 71-79, 1994.
13. PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell, 71: 323-334, 1992.
14. Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., and Kato, J. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol., 14: 2066-2076, 1994.
15. Meyerson, M., and Harlow, E. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol., 14: 2077-2086, 1994.
16. Tam, S., Theodoras, A. M., Shay, J. W., Draetta, G. F., and Pagano, M. Differential expression and regulation of cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for cyclin D1 function in G1 progression. Oncogene, 9: 2663-2674, 1994.
17. Xiong, Y., Zhang, H., and Beach, D. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell, 71: 505-514, 1992.
18. Dulic, V., Lees, E., and Reed, S. I. Association of human cyclin E with a periodic Gl-S phase protein kinase. Science (Washington DC), 257: 1958-1961, 1992.
19. Koff, A., Giordano, A., Desai, D., Yamashita, K., Harper, J. W., Elledge, S., Nishimoto, T., Morgan, D. O., Franza, B. R., and Roberts, J. M. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science (Washington DC), 257: 1689-1693, 1992.
20. Keyomarsi, K., O'Leary, N., Molnar, G., Lees, E., Fingert, H. J., and Pardee, A. B. Cyclin E, a potential prognostic marker for breast cancer. Cancer Res., 54: 380-385, 1994.
21. Nielsen, N. H., Arnerlöv, C., Emdin, S. O., and Landberg, G. Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status. Br. J. Cancer, 74: 874-880, 1996.
22. KIPI and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat. Med., 3: 222-225, 1997.
23. Fujino, M., Dosaka-Akita, H., Harada, M., Hiroumi, H., Kinoshita, I., Akie, K., and Kawakami, Y. Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer. Cancer (Phila.), 76: 2457-2463, 1995.
24. INK4A and retinoblastoma protein status in non-small cell lung cancer: potential synergistic effect with altered p53 protein on proliferative activity. Cancer Res., 56: 5557-5562, 1996.
25. Dosaka-Akita, H., Hu, S., Fujino, M., Harada, M., Kinoshita, I., Xu, H., Kuzumaki, N., Kawakami, Y., and Benedict, W. F. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis. Cancer (Phila.), 79: 1329-1337, 1997.
26. INK4A, retinoblastoma and p53 proteins for the prognosis of non-small-cell lung cancers. Br. J. Cancer, 81: 696-701, 1999.
27. Mishina, T., Dosaka-Akita, H., Kinoshita, I., Hommura, F., Morikawa, T., Katoh, H., and Kawakami, Y. Cyclin D1 expression in non-small cell lung cancers: its association with altered p53 expression, cell proliferation and clinical outcome. Br. J. Cancer, 80: 1289-1295, 1999.
28. WHO. Histological Typing of Lung Tumors, Ed. 2, pp. 25-26. Geneva: WHO, 1981.
29. American Joint Committee on Cancer, Lung. In: O. H. Beahrs, D. E. Henson, R. V. P. Hutter, and B. J. Kennedy, eds. Manual for Staging of Cancer, Ed. 4, pp. 115-122. Philadelphia: J. B. Lippincott Company, 1992.
30. cdk2. J. Virol., 67: 2456-2465, 1993.
31. Dutta, A., Chandra, R., Leiter, L. M., and Lester, S. Cyclins as markers of tumor proliferation: immunohistochemical studies in breast cancer. Proc. Natl. Acad. Sci. USA, 92: 5386-5390, 1995.
32. Langenfeld, J., Lonardo, F., Kiyokawa, H., Passalaris, T., Ahn, M., Rusch, V., and Dmitrovsky, E. Inhibited transformation of immortalized human bronchial epithelial cells by retinoic acid is linked to cyclin E down-regulation. Oncogene, 13: 1983-1990, 1996.
33. Lonardo, F., Rusch, V., Langenfeld, J., Dmitrovsky, E., Klimstra, D. S. Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development. Cancer Res., 59: 2470-2476, 1999.
34. Keyomarsi, K., and Pardee, A. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc. Natl. Acad. Sci. USA, 90: 1112-1116, 1993.
35. Bortner, D. M., and Rosenberg, M. P. Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Mol. Cell. Biol., 17: 453-459, 1997.
36. Keyomarsi, K., Conte, D., Jr., Toyofuku, W., and Fox, M. P. Deregulation of cyclin E in breast cancer. Oncogene, 11: 941-950, 1995.
37. Leach, F. S., Elledge, S. J., Sherr, C. J., Willson, J. K., Markowitz, S., Kinzler, K. W., and Vogelstein, B. Amplification of cyclin genes in colorectal carcinomas. Cancer Res., 53: 1986-1989.
38. Gong, J., Ardelt, B., Traganos, F., and Darzynkiewicz, Z. Unscheduled expression of cyclin B1 and cyclin E in several leukemic and solid tumor cell lines. Cancer Res., 54: 4285-4288, 1994.
39. Wolowiec, D., Benchaib, M., Pernas, P., Deviller, P., Soucher, C., Rimokh, R., Felman, P., Bryon, P. A., and Ffrench, M. Expression of cell cycle regulatory proteins in chronic lymphocytic leukemias. Comparison with non-Hodgkin's lymphomas and non-neoplastic lymphoid tissue. Leukemia (Baltimore), 9: 1382-1387, 1995.
40. Scuderi, R., Palucka, K. A., Pokrovskaja, K., Björkholm, M., Wiman, K. G., and Pisa, P. Cyclin E overexpression in relapsed adult acute lymphoblastic leukemias of B-cell lineage. Blood, 87: 3360-3367, 1996.
41. Spruck, C. H., Won, K., and Reed, S. I. Deregulated cyclin E induces chromosome instability. Nature (Lond.), 401: 297-300, 1999.
42. Sofer-Levi, Y, and Resnitzky, D. Apoptosis induced by ectopic expression of cyclin D1 but not cyclin E. Oncogene, 13: 2431-2437 1996.
43. Del Sal, G., Murphy M., Ruaro, E., Lazarevic, D., Levine, A., and Schneider, C. Cyclin D1 and p21/waf1 are involved in p53 growth suppression. Oncogene, 12: 177-185, 1996.